Itepekimab as add-on maintenance treatment for moderate to severe chronic obstructive pulmonary disease [ID6547]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Tozorakimab for treating exacerbations of chronic obstructive pulmonary disease after optimised inhaled dual or triple therapy [ID6711]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC